Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A

The human cyclin Bl gene is cell cycle regulated with maximal activity during G(2)/M. We examined the role of histone deacetylation in cyclin Bl regulation using the histone deacetylase inhibitor trichostatin A (TSA). TSA treatment (100 ng/ml) of NIH3T3 cells containing the luciferase reporter construct pCycB(-287)-LUC caused an increase in promoter activity in G(0) and G(1) but no significant change in G(2). Removal of upstream sequences including an E-box and Sp1 site eliminated the TSA induced increase in G(0) and G(1), and caused a decrease in promoter activity during S and G(2). Promoter activity increased only 2-fold following TSA treatment of G(0) cells containing the construct pCycB(MUT-E-Box)-LUC with an E-box mutation, and a decrease in activity was detected during G(2). We conclude that histone deacetylation contributes to the repression of cyclin B1 expression in G(0) and G(1), and that this mechanism requires, in part, the E-box. TSA reduction of cyclin B1 promoter activity in G(2), however, involves sequences within the first 119 bp. A working model for cyclin B1 regulation is provided.     

Effects of cover soil stockpiling on plant community development following reclamation of oil sands sites in Alberta

Stockpiling of cover soil can influence vegetation development following reclamation. Cover soil, comprising the upper 15–30 cm of the surface material on sites scheduled for mining, is commonly salvaged prior to mining and used directly or stockpiled for various lengths of time until it is needed. Salvaging and stockpiling causes physical, chemical, and biological changes in cover soils. In particular, stockpiling reduces the availability and vigor of vegetative propagules and seed, and can lead to increases in the abundance of some weedy species. This study uses data from monitoring plots to assess how stockpiling of cover soil impacts plant community development on reclaimed oil sands mine sites in northern Alberta. Development of plant communities differed distinctly between directly placed and stockpiled cover soil treatments even 18 years after reclamation. Direct placement of cover soil resulted in higher percent cover, species richness, and diversity. Nonmetric multidimensional scaling and multiresponse permutation procedure revealed compositional differentiation between the treatments. Indicator species analysis showed that direct placement treatment was dominated by perennial species while grasses and annual forb species dominated sites where stockpiled soil was used. Results indicate that stockpiling leads to slower vegetation recovery while direct placement of cover soil supports more rapid succession (from ruderal and annual communities to perennial communities). In addition, direct placement may be less costly than stockpiling. However, scheduling of salvage and placement remains a challenge.     

Basal insulin, glucagon, and growth hormone replacement

Conclusions drawn from the pancreatic (or islet) clamp technique (suppression of endogenous insulin, glucagon, and growth hormone secretion with somatostatin and replacement of basal hormone levels by intravenous infusion) are critically dependent on the biological appropriateness of the selected doses of the replaced hormones. To assess the appropriateness of representative doses we infused saline alone, insulin (initially 0.20 mU.kg(-1).min(-1)) alone, glucagon (1.0 ng.kg(-1).min(-1)) alone, and growth hormone (3.0 ng.kg(-1).min(-1)) alone intravenously for 4 h in 13 healthy individuals. That dose of insulin raised plasma insulin concentrations approximately threefold, suppressed glucose production, and drove plasma glucose concentrations down to subphysiological levels (65 +/- 3 mg/dl, P < 0.0001 vs. saline), resulting in nearly complete suppression of insulin secretion (P < 0.0001) and stimulation of glucagon (P = 0.0059) and epinephrine (P = 0.0009) secretion. An insulin dose of 0.15 mU.kg(-1).min(-1) caused similar effects, but a dose of 0.10 mU.kg(-1).min(-1) did not. The glucagon and growth hormone infusions did not alter plasma glucose levels or those of glucoregulatory factors. Thus, insulin "replacement" doses of 0.20 and even 0.15 mU.kg(-1).min(-1) are excessive, and conclusions drawn from the pancreatic clamp technique using such doses may need to be reassessed.